CME Group Inc (NASDAQ:CME) CFO John W. Pietrowicz Sells 2,500 Shares

CME Group Inc (NASDAQ:CME) CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $168.27, for a total transaction of $420,675.00. Following the sale, the chief financial officer now directly owns 35,354 shares of the company’s stock, valued at $5,949,017.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of CME opened at $179.01 on Friday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $64.24 billion, a price-to-earnings ratio of 26.25, a P/E/G ratio of 3.57 and a beta of 0.29. CME Group Inc has a 52-week low of $153.90 and a 52-week high of $197.08.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, February 14th. The financial services provider reported $1.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.02. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The company’s quarterly revenue was up 37.4% on a year-over-year basis. During the same period last year, the company earned $1.12 EPS. On average, sell-side analysts forecast that CME Group Inc will post 6.81 EPS for the current fiscal year.

A number of equities research analysts have recently commented on the stock. BidaskClub cut shares of CME Group from a “sell” rating to a “strong sell” rating in a research note on Friday, March 22nd. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, April 9th. Barclays decreased their target price on CME Group from $210.00 to $193.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 26th. Sanford C. Bernstein reiterated an “outperform” rating and set a $210.00 target price on shares of CME Group in a research report on Friday, February 15th. Finally, ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 20th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the stock. CME Group presently has a consensus rating of “Hold” and an average target price of $192.00.

Large investors have recently modified their holdings of the stock. Dubuque Bank & Trust Co. boosted its stake in shares of CME Group by 83.1% in the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after buying an additional 69 shares during the period. Resources Investment Advisors Inc. lifted its stake in CME Group by 2,800.0% during the fourth quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 140 shares during the last quarter. Ruggie Capital Group purchased a new stake in CME Group during the fourth quarter worth approximately $28,000. Smith Asset Management Group LP lifted its stake in CME Group by 200.0% during the fourth quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 100 shares during the last quarter. Finally, Truvestments Capital LLC purchased a new stake in CME Group during the first quarter worth approximately $32,000. 84.83% of the stock is owned by hedge funds and other institutional investors.

WARNING: This article was first reported by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/04/27/insider-selling-cme-group-inc-cme-cfo-sells-2500-shares-of-stock.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Google Finance Portfolio

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.